{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:50:03Z","timestamp":1788306603637,"version":"build-2803163510"},"reference-count":84,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.vaccine.2015.03.055","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T13:05:24Z","timestamp":1428325524000},"page":"2406-2413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Varicella in Europe\u2014A review of the epidemiology and experience with vaccination"],"prefix":"10.1016","volume":"33","author":[{"given":"Ida Glode","family":"Helmuth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla Hiul","family":"Suppli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e5re","family":"M\u00f8lbak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.03.055_bib0425","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","article-title":"Varicella","volume":"368","author":"Heininger","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0430","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1212\/WNL.0000000000000584","article-title":"Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK","volume":"83","author":"Breuer","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0435","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1128\/CMR.00052-13","article-title":"Pathogenesis and current approaches to control of varicella-zoster virus infections","volume":"26","author":"Gershon","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0440","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1471-0528.2011.02983.x","article-title":"Varicella-zoster virus (chickenpox) infection in pregnancy","volume":"118","author":"Lamont","year":"2011","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0445","year":"2015"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0450","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1542\/peds.2008-0567","article-title":"Varicella prevention in the United States: a review of successes and challenges","volume":"122","author":"Marin","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0455","doi-asserted-by":"crossref","first-page":"e1134","DOI":"10.1542\/peds.2013-0863","article-title":"Impact of a routine two-dose varicella vaccination program on varicella epidemiology","volume":"132","author":"Bialek","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0460","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2471\/BLT.13.132142","article-title":"Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study","volume":"92","author":"Heywood","year":"2014","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0465","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00431-007-0424-0","article-title":"Varicella vaccination in Europe: are we ready for a universal childhood programme?","volume":"167","author":"Sengupta","year":"2008","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0470","doi-asserted-by":"crossref","first-page":"e66485","DOI":"10.1371\/journal.pone.0066485","article-title":"Herpes zoster risk reduction through exposure to chickenpox patients: a systematic multidisciplinary review","volume":"8","author":"Ogunjimi","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0475","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/S0264-410X(02)00180-9","article-title":"Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox","volume":"20","author":"Brisson","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0480","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.4161\/hv.23943","article-title":"Secular trends of chickenpox among military population in Israel in relation to introduction of varicella zoster vaccine 1979\u20132010","volume":"9","author":"Mimouni","year":"2013","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0485","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.vaccine.2013.11.008","article-title":"Different vaccination strategies in Spain and its impact on severe varicella and zoster","volume":"32","author":"Gil-Prieto","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0490","doi-asserted-by":"crossref","first-page":"739","DOI":"10.7326\/0003-4819-159-11-201312030-00006","article-title":"Examination of links between herpes zoster incidence and childhood varicella vaccination","volume":"159","author":"Hales","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0495","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1016\/j.vaccine.2007.07.036","article-title":"The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region","volume":"25","author":"Nardone","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0500","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/1471-2458-8-372","article-title":"The epidemiology of varicella zoster virus infection in Italy","volume":"8","author":"Gabutti","year":"2008","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0505","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.vaccine.2007.05.019","article-title":"Susceptibility to varicella in childbearing age women Central Italy: is there a need for vaccinating this population group?","volume":"25","author":"Alfonsi","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0510","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-2334-12-140","article-title":"Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population","volume":"12","author":"Van Rijckevorsel","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0515","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1017\/S0950268807008497","article-title":"The seroepidemiology of varicella zoster virus among pregnant Bangladeshi and white British women in the London Borough of Tower Hamlets, UK","volume":"135","author":"Talukder","year":"2007","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0520","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/1471-2458-12-475","article-title":"Increased seroprevalence of IgG-class antibodies against cytomegalovirus, parvovirus B19, and varicella-zoster virus in women working in child day care","volume":"12","author":"Van Rijckevorsel","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0525","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2010.06.004","article-title":"Kinetics of maternal antibodies against rubella and varicella in infants","volume":"29","author":"Leuridan","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0530","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/infdis\/jit143","article-title":"Waning of maternal antibodies against measles, mumps rubella, and varicella in communities with contrasting vaccination coverage","volume":"208","author":"Waaijenborg","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0535","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1016\/j.vaccine.2006.02.017","article-title":"The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination","volume":"24","author":"De Melker","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0540","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1017\/S0950268811002640","article-title":"The health and economic burden of chickenpox and herpes zoster in Belgium","volume":"140","author":"Bilcke","year":"2012","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0545","doi-asserted-by":"crossref","first-page":"9480","DOI":"10.1016\/j.vaccine.2011.10.022","article-title":"Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy","volume":"29","author":"Pozza","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0550","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1023\/B:EJEP.0000036791.43264.84","article-title":"The burden of severe varicella in Spain, 1995\u20132000 period","volume":"19","author":"Gil","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0555","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1016\/j.vaccine.2004.04.004","article-title":"Epidemiology of severe varicella-zoster virus infection in Spain","volume":"22","author":"Gil","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0560","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S0950268806006467","article-title":"Epidemiology of hospital admissions for paediatric varicella infections: a one-year prospective survey in the pre-vaccine era","volume":"135","author":"Dubos","year":"2007","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0565","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00431-005-0043-6","article-title":"Varicella-related complications and hospitalisations in a tertiary pediatric medical center before vaccine introduction","volume":"165","author":"Theodoridou","year":"2006","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0570","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/INF.0b013e3181586665","article-title":"The burden of varicella complications before the introduction of routine varicella vaccination in Germany","volume":"27","author":"Liese","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0575","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s15010-007-6248-z","article-title":"Hospitalization rates for complicated and uncomplicated chickenpox in a poorly vaccined pediatric population","volume":"35","author":"Bonsignori","year":"2007","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0580","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1017\/S0950268808001131","article-title":"Varicella paediatric hospitalizations in Spain","volume":"137","author":"Guill\u00e9n","year":"2009","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0585","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/adc.2007.123232","article-title":"Severe complications of chickenpox in hospitalised children in the UK and Ireland","volume":"92","author":"Cameron","year":"2007","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0590","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00431-005-1637-8","article-title":"Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents","volume":"164","author":"Bonhoeffer","year":"2005","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0595","first-page":"229","article-title":"Varicella and its complications as cause of hospitalization","volume":"13","author":"Losurdo","year":"2005","journal-title":"Infez Med Riv Period Eziologia Epidemiol Diagn Clin E: Ter Delle Patol Infett"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0600","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/j.1651-2227.2007.00465.x","article-title":"Epidemiology of hospital admissions for chickenpox in children: an Italian multicentre study in the pre-vaccine era","volume":"96","author":"Marchetto","year":"2007","journal-title":"Acta Paediatr Oslo Nor"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0605","doi-asserted-by":"crossref","first-page":"e485","DOI":"10.1016\/j.ijid.2012.11.024","article-title":"Don\u2019t forget how severe varicella can be\u2014complications of varicella in children in a defined Polish population","volume":"17","author":"Gowin","year":"2013","journal-title":"Int J Infect Dis\u2014IJID"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0610","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1469-0691.2007.01706.x","article-title":"Paediatric varicella hospitalisations in France: a nationwide survey","volume":"13","author":"Grimprel","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0615","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-2334-11-85","article-title":"Hospitalization due to varicella in the Netherlands","volume":"11","author":"Van Lier","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0620","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.vaccine.2010.12.095","article-title":"Haematological complications in otherwise healthy children hospitalized for varicella","volume":"29","author":"Bozzola","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0625","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pediatrneurol.2009.07.012","article-title":"Neurologic varicella complications before routine immunization in Germany","volume":"42","author":"Rack","year":"2010","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0630","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jcv.2006.12.020","article-title":"An increasing incidence of chickenpox central nervous system complications in children: what's happening in Tuscany?","volume":"38","author":"Frenos","year":"2007","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0635","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.vaccine.2009.01.019","article-title":"Acute cerebellar ataxia in the Netherlands: a study on the association with vaccinations and varicella zoster infection","volume":"27","author":"van der Maas","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0640","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00431-010-1212-9","article-title":"Hospitalization of newborns and young infants for chickenpox in France","volume":"169","author":"L\u00e9cuyer","year":"2010","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0645","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10096-010-1106-9","article-title":"How frequent is varicella-associated pneumonia in children?","volume":"30","author":"Herv\u00e1s","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0650","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1574-695X.2011.00788.x","article-title":"Invasive group A streptococcal disease and association with varicella in Germany, 1996\u20132009","volume":"62","author":"Im\u00f6hl","year":"2011","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0655","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1651-2227.2007.00595.x","article-title":"Varicella-related deaths in children and adolescents\u2014Germany 2003\u20132004","volume":"97","author":"Grote","year":"2008","journal-title":"Acta Paediatr Oslo Nor"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0660","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4161\/hv.6.8.12014","article-title":"Burden of adult varicella hospitalizations in Spain (2001\u20132007)","volume":"6","author":"Guillen","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0665","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1471-2334-12-110","article-title":"Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands","volume":"12","author":"Pierik","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0670","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1016\/j.vaccine.2014.04.034","article-title":"Low varicella-related consultation rate in the Netherlands in primary care data","volume":"32","author":"Van Lier","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0675","doi-asserted-by":"crossref","first-page":"843","DOI":"10.4161\/hv.9897","article-title":"Prospective surveillance of varicella-zoster virus infections in an out-patient setting in Switzerland","volume":"5","author":"Iseli","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0680","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1469-0691.2004.00853.x","article-title":"Empirical data on the varicella situation in Germany for vaccination decisions","volume":"10","author":"Wagenpfeil","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0685","doi-asserted-by":"crossref","DOI":"10.2807\/ese.15.16.19548-en","article-title":"Changes to the varicella and pertussis immunisation schedule in Germany 2009: background, rationale and implementation","volume":"15","author":"Wiese-Posselt","year":"2010","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2013.12.065","article-title":"Decline of varicella vaccination in German surveillance regions after recommendation of separate first-dose vaccination for varicella and measles\u2013mumps\u2013rubella","author":"Streng","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0695","doi-asserted-by":"crossref","first-page":"476","DOI":"10.4161\/hv.26986","article-title":"Vaccination coverage among children in Germany estimated by analysis of health insurance claims data","volume":"10","author":"Rieck","year":"2014","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0700","doi-asserted-by":"crossref","DOI":"10.2807\/ese.15.13.19530-en","article-title":"Impact of the routine varicella vaccination programme on varicella epidemiology in Germany","volume":"15","author":"Siedler","year":"2010","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0705","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/INF.0b013e3181e2817f","article-title":"Complications of varicella after implementation of routine childhood varicella vaccination in Germany","volume":"29","author":"Spackova","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0710","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1016\/j.vaccine.2010.06.007","article-title":"Varicella vaccination coverage in Bavaria (Germany) after general vaccine recommendation in 2004","volume":"28","author":"Streng","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0715","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/1471-2334-13-303","article-title":"Varicella routine vaccination and the effects on varicella epidemiology\u2014results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006\u20132011","volume":"13","author":"Streng","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0720","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1017\/S0950268810002815","article-title":"Assessment of varicella vaccine effectiveness in Germany: a time-series approach","volume":"139","author":"H\u00f6hle","year":"2011","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0725","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/INF.0b013e31829ae263","article-title":"The effectiveness of varicella vaccination in children in Germany: a case\u2013control study","volume":"32","author":"Liese","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0730","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.4161\/hv.23451","article-title":"Effectiveness of one and two doses of varicella vaccine in preventing laboratory-confirmed cases in children in Navarre Spain","volume":"9","author":"Cenoz","year":"2013","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0735","doi-asserted-by":"crossref","first-page":"20552","DOI":"10.2807\/1560-7917.ES2013.18.32.20552","article-title":"Impact of universal two-dose vaccination on varicella epidemiology in Navarre, Spain, 2006 to 2012","volume":"18","author":"Garc\u00eda Cenoz","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0740","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.1016\/j.vaccine.2014.10.076","article-title":"Varicella vaccination coverage inverse correlation with varicella hospitalizations in Spain","volume":"32","author":"Gil-Prieto","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0745","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.healthpol.2011.10.002","article-title":"Regional Coordinators for Infectious Diseases and Vaccinations Current immunization policies for pneumococcal, meningococcal C, varicella and rotavirus vaccinations in Italy","volume":"103","author":"Alfonsi","year":"2011","journal-title":"Health Policy Amst Neth"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0750","first-page":"e34311","article-title":"Impact of universal vaccination against varicella in Italy","author":"Bechini","year":"2014","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0755","article-title":"The impact of ten years of infant universal Varicella vaccination in Sicily Italy (2003\u20132012)","volume":"11","author":"Amodio","year":"2014","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0760","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4161\/hv.36153","article-title":"Effectiveness of vaccination against varicella in children under 5 years in Puglia Italy 2006\u20132012","volume":"11","author":"Tafuri","year":"2014","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0765","first-page":"E071101.3","article-title":"Universal varicella vaccination in the Veneto Region Italy: launch of a programme targeting all children aged 14 months and susceptible adolescents","volume":"12","author":"Baldo","year":"2007","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0770","doi-asserted-by":"crossref","DOI":"10.2807\/ese.14.35.19321-en","article-title":"Universal varicella vaccination in the Sicilian paediatric population: rapid uptake of the vaccination programme and morbidity trends over five years","volume":"14","author":"Giammanco","year":"2009","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0775","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2334-9-150","article-title":"Varicella: epidemiological aspects and vaccination coverage in the Veneto Region","volume":"9","author":"Baldo","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0780","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1016\/j.vaccine.2013.08.029","article-title":"Varicella zoster virus infection occurs at a relatively young age in The Netherlands","volume":"31","author":"Van Lier","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0785","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00404-012-2398-z","article-title":"Immunity to varicella-zoster virus in Croatian women of reproductive age targeted for serology testing","volume":"286","author":"Vilibic-Cavlek","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0790","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1128\/CVI.00348-06","article-title":"Genotypic analysis of varicella-zoster virus and its seroprevalence in Finland","volume":"14","author":"Koskiniemi","year":"2007","journal-title":"Clin Vaccine Immunol CVI"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0795","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.inf.0000195636.43584.bb","article-title":"Seroprevalence of varicella in the French population","volume":"25","author":"Khoshnood","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0800","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10654-007-9136-z","article-title":"Seroprevalence of varicella antibodies among pregnant women in Lyon\u2013France","volume":"22","author":"Saadatian-Elahi","year":"2007","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0805","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1017\/S0950268804002754","article-title":"Seroprevalence and force of infection of varicella-zoster virus in Luxembourg","volume":"132","author":"Mossong","year":"2004","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0810","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/1471-2458-10-360","article-title":"Varicella susceptibility and transmission dynamics in Slovenia","volume":"10","author":"Socan","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0815","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4161\/hv.1.5.2216","article-title":"Seroprevalence of varicella among children and adolescents in Valencia Spain. Reliability of the parent's reported history and the medical file for identification of potential candidates for vaccination","volume":"1","author":"Diez-Domingo","year":"2005","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0820","doi-asserted-by":"crossref","first-page":"41","DOI":"10.21101\/cejph.a3454","article-title":"Seroprevalence of antibodies to varicella-zoster virus in Madrid (Spain) in the absence of vaccination","volume":"16","author":"Perez-Farinos","year":"2008","journal-title":"Cent Eur J Public Health"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0825","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00430-007-0064-z","article-title":"Seroprevalence of varicella zoster virus infection in child and adult population of Catalonia (Spain)","volume":"197","author":"Salleras","year":"2008","journal-title":"Med Microbiol Immunol (Berl)"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0830","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1016\/j.vaccine.2014.08.055","article-title":"Varicella-zoster virus immunity among health care workers in Catalonia","volume":"32","author":"Urbiztondo","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0835","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jcv.2006.07.012","article-title":"Changes in seroprevalence to four herpesviruses over 30 years in Swedish children aged 9\u201312 years","volume":"37","author":"Svahn","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2015.03.055_bib0840","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1017\/S0950268804003140","article-title":"Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults","volume":"132","author":"Vyse","year":"2004","journal-title":"Epidemiol Infect"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15003655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15003655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T12:15:38Z","timestamp":1651666538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15003655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":84,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0264410X15003655"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Varicella in Europe\u2014A review of the epidemiology and experience with vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}